16 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
19746963	43	Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistance.	Purdue University
19473017	12	Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.	Purdue University
18783203	15	Flexible cyclic ethers/polyethers as novel P2-ligands for HIV-1 protease inhibitors: design, synthesis, biological evaluation, and protein-ligand X-ray studies.	Purdue University
10387041	7	Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease.	University of Queensland
16913714	4	Structure-Based Design of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance.	Purdue University
16904316	16	New, potent P1/P2-morpholinone-based HIV-protease inhibitors.	Glaxosmithkline
16480871	12	Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands.	Purdue University
9871583	7	Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere.	University of Illinois At Chicago
15887965	10	Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.	University of Illinois At Chicago
12113826	23	Novel cyclourethane-derived HIV protease inhibitors: a ring-closing olefin metathesis based strategy.	University of Illinois At Chicago
12419377	5	Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease.	Glaxosmithkline
10866371	12	Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds.	Glaxosmithkline
15482949	17	Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties.	Glaxosmithkline
15482948	7	Potent inhibitors of the HIV-1 protease incorporating cyclic urea P1-P2 scaffold.	Glaxosmithkline
15582415	17	Optimization of pyrrolidinone based HIV protease inhibitors.	Glaxosmithkline
15975788	23	Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.	Glaxosmithkline